Skip to main content
OpenTrials
Completed

NCT Number: NCT05022979

Prevalence and Risk Factors for Micronutrient Deficiencies During Pregnancy in Cayenne, French Guiana

Micronutrient deficiencies are frequent in pregnant women in French Guiana, a French territory in South America. Micronutrient deficiencies are more frequent in precarious women. Obesity is a frequent problem but it is also associated with micronutrient deficiency. Micronutrient deficiencies have largely been overlooked in this outermost European region and should be corrected.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

Female

Study type

Observational

Primary location

General Hospital of Cayenne

Cayenne, 97306, French Guiana

About this study

Involved in physical and brain development, immunity and metabolism, micronutrients have profound health effects. The nutritional status of pregnant women is a major determinant of fetal health. French Guiana has a rapid population growth. Social inequalities, cultural practices and gastrointestinal nematode infections in French Guiana could affect the prevalence of these deficiencies. The main objective of the present study was to estimate the prevalence of micronutrient deficiency among pregnant women in French Guiana. The secondary objective was to identify socio-demographic, dietary, obstetrical and neonatal risk factors associated with deficiencies.

Pregnant women over 22 weeks of pregnancy hospitalized for delivery at the Obstetrical Emergency Department of the Hospital Center in Cayenne from May 2018 to March 2019 were included. A socio-demographic and food questionnaire was administered. Medical data were collected from the medical records. Blood and urine samples were taken. The descriptive analysis used Student and Chi2 tests.

A total of 341 women were included. The majority were born in Haiti (39%) and French Guiana (34%). At least one micronutrient deficiency was observed in 81% of women. Precarious women had a significantly greater risk of micronutrient deficiency during pregnancy compared to those with both normal and complementary health insurance.

Micronutrient deficiencies in pregnant women in French Guiana are a public health problem, a fact that was previously overlooked in a context of rising obesity. With over half of women overweight or obese and 81% with at least 1 micronutrient deficiency, balanced nutrition should be a major focus.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pregnant at least 22 weeks of amenorrhea (WHO threshold for fetal viability)
  • Patient hospitalized for delivery in the Gynecological and Obstetrical Emergency Unit at Cayenne hospital
  • Patient's consent
  • Consent of the legal representative if the patient is a minor

Exclusion criteria

  • Refusalto participate in the study.
  • Being under guardianship or curatorship
  • Having been previously enrolled in the study

Treatment and study plan

Observational only

Other

The investigator collected the patient's data from the medical record and interviewed the patient to complete the nutritional questionnaire.

The required biological, blood and urine samples were collected during routine blood sampling upon entry and hospitalization.

Primary outcomes

  1. Identification of a micronutrient deficiency defined as at least one micronutrient below the lower limit.

    Time frame: 1 day

    • urinary iodine < 100 µg/L
    • blood zinc level < 70 µg/dL
    • magnesium < 0.75 mmol/L
    • serum retinol < 0.70 µmol/L
    • erythrocyte folate < 305 nmol/L
    • blood cobalamin level < 150 pmol/L
    • Martial status: ferritin < 20 µg/L; serum iron < 15 µg/L; iron saturation coefficient of transferrin < 16%.

Secondary outcomes

  1. Sociodemographic information

    Time frame: 1 day

    Socio-demographic and dietary risk factors associated with micronutrient deficiencies were investigated using a structured questionnaire.

  2. assessment of Food diversity score

    Time frame: 1 day

    The food diversity score was inspired by the Food and Agriculture Organization's reports was assessed through a 24h recall, and calculated by adding the number of unique food groups consumed during last 24 hours.

  3. Obstetrical and neonatal outcomes

    Time frame: 1 day

    Obstetrical and neonatal pathologies associated with micronutrient deficiencies were studied throughpatient interrogation and by analyzing medical records: rate of preeclampsia

  4. Newborn health status

    Time frame: 1 day

    Gestational age at delivery, mode of delivery, weight, height, height, head circumference, APGAR, pathologies diagnosed on clinical examination before the 8th day of life

  5. Mother Health status

    Time frame: 1 day

    Weight before pregnancy and on the day of inclusion, height, gestational age, pregnancy follow-up, microcytic anemia (hemoglobinemia <110 g/L, GMV >80 fl), primary hypothyroidism (increased TSH), gynaecological-obstetrical history, personal history of goiter or dysthyroidism, history of night blindness, personal history of anemia, other chronic conditions, history of digestive disorder/parasitoses, malaria history, drug treatment before and during pregnancy, micronutrient supplementation before and during pregnancy, tobacco use during pregnancy, alcohol use during pregnancy

Sponsors and collaborators

Lead sponsor

Centre Hospitalier de Cayenne

Other

Registry information

Official study title

Prevalence of Micro-nutritional Deficiencies in Pregnant Women Presenting to the Emergency Department for Threatened Delivery

Acronym: CarMa

Important dates

Study start
2018
Primary completion
2018
Study completion
2019
First posted
Aug 26, 2021
Registry last updated
Aug 26, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.